Go offline with the Player FM app!
Gynecologic Oncology | Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer
Manage episode 236373277 series 1464173
Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Robert L Coleman, Prof Jonathan A Ledermann, Dr Stephanie Lheureux and Dr Kathleen Moore:
- Genomic Testing and Management of Primary Ovarian Cancer — Dr Moore (00:00)
- Role of PARP Inhibition in the Management of Relapsed Ovarian Cancer — Prof Ledermann (10:37)
- Prevention, Recognition and Management of PARP Inhibitor-Associated Side Effects — Dr Coleman (21:04)
- Investigational Applications of Approved PARP Inhibitors; Other PARP Inhibitors in Clinical Development — Dr Lheureux (29:33)
1441 episodes
Manage episode 236373277 series 1464173
Faculty presentations from an independent satellite symposium during the Society of Gynecologic Oncology’s 2019 Annual Meeting on Women’s Cancer. Featuring perspectives from Dr Robert L Coleman, Prof Jonathan A Ledermann, Dr Stephanie Lheureux and Dr Kathleen Moore:
- Genomic Testing and Management of Primary Ovarian Cancer — Dr Moore (00:00)
- Role of PARP Inhibition in the Management of Relapsed Ovarian Cancer — Prof Ledermann (10:37)
- Prevention, Recognition and Management of PARP Inhibitor-Associated Side Effects — Dr Coleman (21:04)
- Investigational Applications of Approved PARP Inhibitors; Other PARP Inhibitors in Clinical Development — Dr Lheureux (29:33)
1441 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.